Novo Nordisk Seeks Extra-Fast Nod From FDA for Higher Dose of Wegovy
Wedoany.com Report-Dec.1, Novo Nordisk has submitted a regulatory filing to the U.S. Food and Drug A...
Zydus Life Gets US FDA Nod for Generic Version of Antidiabetic Combination Drug Glyxambi
Wedoany.com Report-Dec.1, Zydus Lifesciences has received tentative approval from the United States ...
Iraq to Open Largest Cancer Drug Factory in December
Wedoany.com Report-Nov. 30, Iraq is set to open the region’s largest cancer drug manufacturing facil...
EU Approves Sanofi and Regeneron’s Dupixent as First Targeted CSU Treatment in More Than a Decade
Wedoany.com Report-Nov. 29, The European Commission has approved Dupixent (dupilumab), developed by ...
Innovent Gets Ok for China’s First Home-Grown Il-23p19 Drug
Wedoany.com Report-Nov. 29, Innovent Biologics has received approval from China\'s National Medical ...
Over Half of European HIV Patients Diagnosed Late, ECDC Report Finds
Wedoany.com Report-Nov. 29, The European Centre for Disease Prevention and Control (ECDC) released i...
Celltrion Secures Health Canada Go-Ahead for Eylea Biosimilar
Wedoany.com Report-Nov. 29, Health Canada has granted regulatory approval to Celltrion\'s Eydenzelt ...
Novartis Korea Secures Reimbursement for Cosentyx in Hidradenitis Suppurativa
Wedoany.com Report-Nov. 28, Novartis Korea has announced that Cosentyx (secukinumab), its interleuki...
FDA Approves Treatment for Bladder Cancer
Wedoany.com Report-Nov. 28, The US Food and Drug Administration has approved two regimens combining ...
SK Bolsters Oncology Pipeline in Radiopharmaceutical Licensing Deal
Wedoany.com Report-Nov. 28, SK Biopharmaceuticals has expanded its oncology pipeline by in-licensing...